Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,860 | -32,290 | -18,660 | -9,950 | -5,110 |
| Depreciation Amortization | 1,200 | 5,640 | 4,610 | 3,000 | 1,460 |
| Other Working Capital | 4,250 | 4,900 | 1,670 | 150 | 1,100 |
| Other Operating Activity | -2,830 | -3,780 | -6,030 | -5,430 | -3,080 |
| Operating Cash Flow | $-8,240 | $-25,530 | $-18,410 | $-12,230 | $-5,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -2,970 | -2,140 | -840 | -350 |
| Net Acquisitions | 0 | 2,230 | 0 | 0 | 0 |
| Other Investing Activity | 16,660 | 27,160 | 16,530 | 12,990 | 3,280 |
| Investing Cash Flow | $16,610 | $26,420 | $14,390 | $12,150 | $2,930 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -450 | -1,310 | -740 | -740 | 10 |
| Financing Cash Flow | $-450 | $-1,310 | $-740 | $-740 | $10 |
| Exchange Rate Effect | -1,330 | 1,330 | 1,070 | 550 | 50 |
| Beginning Cash Position | 10,270 | 9,350 | 9,350 | 9,350 | 9,350 |
| End Cash Position | 16,850 | 10,270 | 5,660 | 9,080 | 6,720 |
| Net Cash Flow | $6,580 | $910 | $-3,690 | $-270 | $-2,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,240 | -25,530 | -18,410 | -12,230 | -5,630 |
| Free Cash Flow | -8,240 | -25,530 | -18,410 | -12,230 | -5,630 |